Sign In

Belinda Nivaggioli

President and CEO at QuRetino Therapeutics

Dr. Belinda Nivaggioli is an accomplished professional with a strong background in Bioorganic Chemistry.

She pursued her education diligently, attaining a Bachelor's Degree in Chemistry from Oberlin College, a Master's Degree, and a Ph.D. in Bioorganic Chemistry from the University of Toronto, and a Post-Doctorate in the same field from the prestigious Massachusetts Institute of Technology.

Dr. Nivaggioli has held key positions in various organizations, showcasing her leadership and expertise. She is currently the CEO of Avicena Group, Inc., a role that requires strategic vision and managerial skills.

Prior to her current position, she served as the President and CEO of QuRetino Therapeutics, illustrating her proficiency in the pharmaceutical industry. Her experience also includes a managerial role at Oral-B Labs and a research position at The Gillette Company, reflecting her diverse skill set and adaptability.

Dr. Nivaggioli's career trajectory highlights her commitment to scientific advancement and business acumen, making her a prominent figure in the field of Bioorganic Chemistry and the corporate world.

Belinda Nivaggioli
Add to my network

Location

San Francisco Bay Area